15 Stocks that Insiders Love in 2018

Share on StockTwits

An insider trade occurs when a corporate executive (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Company insiders are required by law to regularly report their stock purchases and sales to the SEC.

Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. If a number of insiders purchase more shares of their company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

For example, if Microsoft's CEO, CFO and COO all recently purchased additional shares of Microsoft stock, that would be an indication that there could be unreported news that may positively effect Microsoft's stock price in the near future.

This slideshow lists the 15 companies that have had the highest levels of insider buying within the last 180 days.

#1 - Sprint (NYSE:S)

Dollar Amount of Shares Purchased: $421,783,445.50
Number of Insider Purchases in the Last 180 Days: 18
Volume of Shares Purchased: 72,408,783
Who Bought Shares: Group Corp Softbank (Major Shareholder)

Insider Trades by Quarter for Sprint (NYSE:S)

Sprint logoSprint Corporation, through its subsidiaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands. The company operates in two segments, Wireless and Wireline. The Wireless segment offers wireless data communication services, including mobile productivity applications, such as Internet access, messaging, and email services; wireless photo and video offerings; location-based capabilities comprising asset and fleet management, dispatch services, and navigation tools; and mobile entertainment applications. It also provides wireless voice communications services that include local and long-distance wireless voice services, as well as voicemail, call waiting, three-way calling, caller identification, directory assistance, and call forwarding services. In addition, this segment offers voice and data services internationally through roaming arrangements; and customized wireless services to large companies and government agencies, as well as sells wireless devices, broadband devices, connected devices, and accessories to agents and other third-party distributors. The Wireline segment provides wireline voice and data communications, including domestic and international data communications using various protocols, such as multiprotocol label switching technologies, Internet protocol (IP), managed network services, Voice over IP, session initiated protocol, and traditional voice services to other communications companies, and targeted business subscribers. Sprint Corporation offers its services under the Sprint, Boost Mobile, Virgin Mobile, and Assurance Wireless brands. It offers products through its 300 branded retail locations in the Southern California region. The company was founded in 1899 and is headquartered in Overland Park, Kansas. Sprint Corporation is a subsidiary of SoftBank Group Corp.

#2 - WillScot (NASDAQ:WSC)

Dollar Amount of Shares Purchased: $415,381,449.60
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 43,268,901
Who Bought Shares: Holding SA RL Sapphire (Major Shareholder)

Insider Trades by Quarter for WillScot (NASDAQ:WSC)

WillScot logoWillScot Corporation, through its subsidiaries, provides various specialty rental services in the United States, Canada, and Mexico. It is involved in the leasing and sale of mobile offices, modular buildings, and storage products. The company's products include single mobile and sales office units, multi-unit office complexes, classrooms, ground-level and stackable steel-frame office units, and other specialty units and shipping containers for portable storage solutions. It also provides value-added products and services, such as steps, ramps, furniture packages, damage waivers, and other amenities rental services; and delivery, installation, lease units removal, and other ancillary products and services. In addition, the company sells new and used units; and offers remote workforce accommodation solutions. It serves customers in the construction, education, healthcare, government, retail, commercial, transportation, security, energy, industrial, natural resources, and other sectors primarily under the Williams Scotsman and Target Logistics names. The company's fleet comprises approximately 100,000 modular space and portable storage units. The company is headquartered in Baltimore, Maryland.

#3 - Coty (NYSE:COTY)

Dollar Amount of Shares Purchased: $284,431,460.00
Number of Insider Purchases in the Last 180 Days: 6
Volume of Shares Purchased: 15,654,000
Who Bought Shares: Cosmetics BV Jab (Major Shareholder) and Edgar O Huber (Insider)

Insider Trades by Quarter for Coty (NYSE:COTY)

Coty logoCoty Inc., together with its subsidiaries, manufactures, markets, sells, and distributes beauty products worldwide. It operates in three segments: Consumer Beauty, Luxury, and Professional Beauty. The Consumer Beauty segment offers color cosmetics, retail hair coloring and styling products, body care products, and mass fragrances primarily through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, and traditional food and drug retailers, as well as own branded e-commerce and direct to consumer Websites. The Luxury segment provides prestige fragrances, and premium skincare and cosmetics products across various regions and luxury channels, including upscale perfumeries, upscale department stores and duty-free shops, and travel retail sales channels. The Professional Beauty segment offers hair and nail care, and other salon products to nail and hair salons, nail and hair professionals, and professionals stores. The company markets and sells its products under the Astor, Bourjois, Clairol, Coty, COVERGIRL, Joop!, Jovan, Lancaster, Manhattan, Max Factor, Nioxin, N.Y.C. New York Color, OPI, philosophy, Rimmel, Sally Hansen, System Professional, and Wella brands. Coty Inc. also sells its products through third-party distributors. The company was founded in 1904 and is headquartered in New York, New York.

#4 - Ecolab (NYSE:ECL)

Dollar Amount of Shares Purchased: $248,638,861.89
Number of Insider Purchases in the Last 180 Days: 7
Volume of Shares Purchased: 1,848,979
Who Bought Shares: David Maclennan (Director), Jeffrey M Ettinger (Director) and William H Gates III (Major Shareholder)

Insider Trades by Quarter for Ecolab (NYSE:ECL)

Ecolab logoEcolab Inc. provides water, hygiene and energy technologies and services. The Company's cleaning and sanitizing programs and products, pest elimination services and equipment maintenance and repair services support customers in the foodservice, food and beverage processing, hospitality, healthcare, government and education, retail, textile care and commercial facilities management sectors in over 170 countries. Its segments include Global Industrial, Global Institutional, Global Energy, Other and Corporate. Its Global Industrial segment consists of the Water, Food and Beverage, Paper and Textile Care operating units. Its Global Institutional segment consists of the Institutional, Specialty and Healthcare operating units. The Global Energy segment provides on-site and technology-driven solutions to the global drilling, oil and gas production, refining, and petrochemical industries. The Company's Other segment consists of the Pest Elimination operating units.

#5 - BeiGene (NASDAQ:BGNE)

Dollar Amount of Shares Purchased: $199,999,998.00
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 1,980,198
Who Bought Shares: Bros Advisors Lp Baker (Director)

Insider Trades by Quarter for BeiGene (NASDAQ:BGNE)

BeiGene logoBeiGene, Ltd., a clinical-stage biopharmaceutical company, develops and commercializes molecularly-targeted and immuno-oncology drugs for the treatment of cancer. Its commercial products include ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancer; REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma in combination with dexamethasone; and VIDAZA, a pyrimidine nucleoside analog for the treatment of intermediate-2 and high-risk myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia with 20% to 30% blasts and multi-lineage dysplasia. The company's clinical stage drug candidates include BGB-3111, a small molecule Bruton's tyrosine kinase (BTK) inhibitor for the treatment of various lymphomas; BGB-A317, a humanized monoclonal antibody for solid and hematological cancers; BGB-290, a small molecule inhibitor of PARP1 and PARP2 for the treatment of homologous recombination deficient cancers; BGB-283, a small molecule RAF dimer inhibitor to treat cancers with aberrations in the mitogen-activated protein kinase pathway, including BRAF mutations and KRAS/NRAS gene mutations; BGB-A333, an humanized monoclonal antibody for the immune checkpoint receptor ligand PD-L1; and MGCD-0516, a multi-kinase inhibitor. Its preclinical programs consists of targeted therapies and immuno-oncology agents, including an additional RAF dimer inhibitor, a TIM-3 cell surface protein monoclonal antibody, and a BTK inhibitor for non-oncology indications. The company has a strategic collaboration with Celgene Corporation to research and develop BeiGene, Ltd.'s investigational anti-programmed cell death protein 1 (PD-1) inhibitor, BGB-A317; and with Merck KGaA to research and develop on BGB-290 and BGB-283. BeiGene, Ltd. was founded in 2010 and is based in George Town, the Cayman Islands.

#6 - Akcea Therapeutics (NASDAQ:AKCA)

Dollar Amount of Shares Purchased: $199,999,987.50
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 10,666,666
Who Bought Shares: Ionis Pharmaceuticals Inc (Major Shareholder)

Insider Trades by Quarter for Akcea Therapeutics (NASDAQ:AKCA)

Akcea Therapeutics logoAkcea Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. It develops Volanesorsen, which has completed Phase 3 clinical study for the treatment of familial chylomicronemia syndrome; and that is in Phase 3 clinical study for the treatment of familial partial lipodystrophy. The company also develops AKCEA-APO(a)-LRx, which has completed Phase 2b clinical study for treating patients suffering with hyperlipoproteinemia; AKCEA-ANGPTL3-LRx that has completed Phase 1/2 clinical study for the treatment of multiple lipid disorders; and AKCEA-APOCIII-LRx, which is in Phase 1/2 study for the treatment of cardiovascular disease due to elevated triglyceride levels. It has strategic collaboration with Novartis Pharma AG. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Akcea Therapeutics, Inc. is a subsidiary of Ionis Pharmaceuticals, Inc.

#7 - Seattle Genetics (NASDAQ:SGEN)

Dollar Amount of Shares Purchased: $199,999,956.00
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 3,846,153
Who Bought Shares: Bros Advisors Lp Baker (Director)

Insider Trades by Quarter for Seattle Genetics (NASDAQ:SGEN)

Seattle Genetics logoSeattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS, an antibody-drug conjugate for the treatment of relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma. The company also develops enfortumab vedotin, which is in Phase 1 clinical trial for Nectin-4-positive solid tumors, including bladder cancer; and tisotumab vedotin that is in Phase II clinical trial for patients with cervical cancer and solid tumors. In addition, it conducts phase 3 clinical trials of ADCETRIS which includes ECHELON-1 for patients with newly diagnosed advanced stage classical Hodgkin lymphoma; ECHELON-2 for patients with newly diagnosed CD30-expressing MTCL; and the CHECKMATE 812 for patients with relapsed or refractory or transplant-ineligible, and advanced classical Hodgkin lymphoma. Further, the company's earlier stage clinical pipeline includes six other ADC programs consisting of ladiratuzumab vedotin, denintuzumab mafodotin, SGN-CD19B, SGN-CD123A, SGN-CD33A, and SGN-CD352A, as well as two immuno-oncology agents, including SEA-CD40 and SGN-2FF. It has collaborations for its ADC technology with various biotechnology and pharmaceutical companies, including AbbVie Biotechnology Ltd.; Bayer Pharma AG; Celldex Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline LLC; Pfizer, Inc., PSMA Development Company LLC; Takeda Pharmaceutical Company Limited, Unum Therapeutics, Inc., and Genmab A/S, as well as has co-development agreement with Agensys, Inc. Seattle Genetics, Inc. was founded in 1998 and is headquartered in Bothell, Washington.

#8 - Myovant Sciences (NYSE:MYOV)

Dollar Amount of Shares Purchased: $161,043,072.80
Number of Insider Purchases in the Last 180 Days: 2
Volume of Shares Purchased: 8,530,640
Who Bought Shares: Holdings Ltd Dexxon (Major Shareholder) and Pharmaceuticals Interna Takeda (Major Shareholder)

Insider Trades by Quarter for Myovant Sciences (NYSE:MYOV)

Myovant Sciences logoMyovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of the hormonal preparation used in assisted reproduction. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was founded in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Roivant Sciences Ltd.

#9 - Buffalo Wild Wings (NASDAQ:BWLD)

Dollar Amount of Shares Purchased: $148,770,000.00
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 950,000
Who Bought Shares: International Master F Marcato (Director)

Insider Trades by Quarter for Buffalo Wild Wings (NASDAQ:BWLD)

Buffalo Wild Wings logoBuffalo Wild Wings, Inc. is the owner, operator and franchisor of restaurants. As of December 25, 2016, the Company's made-to-order menu items included 16 sauces and five seasonings, ranging from Sweet BBQ to Blazin. The Company's restaurants offer 20 to 40 domestic and imported beers on tap, including craft brews, and a selection of bottled beers, wines and liquor. As of December 25, 2016, the Company had company-owned or franchised restaurants in all 50 states and two Canadian provinces. Its franchised restaurants also operate in Mexico, Saudi Arabia, Philippines, Panama and the United Arab Emirates. The Company operates Buffalo Wild Wings, R Taco and PizzaRev restaurants, as well as sells Buffalo Wild Wings and R Taco restaurant franchises. In addition to traditional and boneless chicken wings, the Company's menu features a range of food items, including sharables, hamburgers, sandwiches, wraps, Buffalito soft tacos, and salads.

#10 - Avis Budget Group (NASDAQ:CAR)

Dollar Amount of Shares Purchased: $141,960,000.00
Number of Insider Purchases in the Last 180 Days: 1
Volume of Shares Purchased: 3,500,000
Who Bought Shares: Srs Investment Management, Llc (Major Shareholder)

Insider Trades by Quarter for Avis Budget Group (NASDAQ:CAR)

Avis Budget Group logoAvis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary services to businesses and consumers worldwide. It operates the Avis brand, a vehicle rental system with approximately 5,450 locations that supply rental cars to the premium commercial and leisure segments of the travel industry; the Budget brand, a vehicle rental and other mobility solutions primarily focuses on the value-conscious segments of the industry; the Zipcar brand, a membership-based car sharing network; and the Budget Truck brand, a local and one-way truck rental businesses with a fleet of approximately 19,000 vehicles, which are rented through a network of approximately 925 dealer-operated and 450 company-operated locations that serve the consumer and light commercial sectors in the continental United States. The company also operates the Payless brand, which comprises approximately 280 vehicle rental locations; the Apex brand that primarily in the deep-value segment of the car rental industry with approximately 25 rental locations in New Zealand and Australia; and the Maggiore brand that provides vehicle rental services in approximately 140 locations, as well as the France Cars brand, which offers light commercial vehicle fleets with approximately 70 rental locations in France. In addition, it offers optional insurance products and coverages, such as supplemental liability, personal accident, personal effects protection, emergency sickness protection, automobile towing protection, and cargo insurance products. The company was formerly known as Cendant Corporation and changed its name to Avis Budget Group, Inc. in September 2006. Avis Budget Group, Inc. was founded in 1946 and is headquartered in Parsippany, New Jersey.

#11 - Trinity Industries (NYSE:TRN)

Dollar Amount of Shares Purchased: $141,242,499.48
Number of Insider Purchases in the Last 180 Days: 13
Volume of Shares Purchased: 4,346,624
Who Bought Shares: Holdings LP Valueact (Major Shareholder) and Valueact Capital Master Fund, (Major Shareholder)

Insider Trades by Quarter for Trinity Industries (NYSE:TRN)

Trinity Industries logoTrinity Industries, Inc. is a diversified industrial company that owns businesses providing products and services to the energy, chemical, agriculture, transportation and construction sectors. The Company's products and services include railcars and railcar parts; parts and steel components; the leasing, management and maintenance of railcars; highway products; construction aggregates; inland barges; structural wind towers; steel utility structures; storage and distribution containers, and trench shields and shoring products. The Company's segments include the Rail Group, Construction Products Group, Inland Barge Group, Energy Equipment Group, Railcar Leasing and Management Services Group, and All Other. Its All Other segment includes its captive insurance and transportation companies, and other peripheral businesses. It manufactures a line of railcars, including autorack cars, box cars, covered hopper cars, gondola cars, intermodal cars, open hopper cars and tank cars.

#12 - Chipotle Mexican Grill (NYSE:CMG)

Dollar Amount of Shares Purchased: $134,819,781.08
Number of Insider Purchases in the Last 180 Days: 3
Volume of Shares Purchased: 423,822
Who Bought Shares: Ali Namvar (Director), Paul T Cappuccio (Director) and Pershing Square Capital Manage (Director)

Insider Trades by Quarter for Chipotle Mexican Grill (NYSE:CMG)

Chipotle Mexican Grill logoChipotle Mexican Grill, Inc., together with its subsidiaries, operates Chipotle Mexican Grill restaurants. As of December 31, 2017, it operated 2,363 Chipotle restaurants throughout the United States, as well as 37 international Chipotle restaurants; and 8 non-Chipotle restaurants. The company was founded in 1993 and is based in Denver, Colorado.

#13 - CenturyLink (NYSE:CTL)

Dollar Amount of Shares Purchased: $129,562,503.56
Number of Insider Purchases in the Last 180 Days: 7
Volume of Shares Purchased: 7,770,713
Who Bought Shares: Glen F Post III (CEO), Harvey P Perry (Chairman), Holdings (Private) Ltd Temasek (Major Shareholder), Jeffrey K Storey (COO), Martha Helena Bejar (Director), Virginia Boulet (Director) and William Bruce Hanks (Vice Chairman)

Insider Trades by Quarter for CenturyLink (NYSE:CTL)

CenturyLink logoCenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers primarily in the United States. It operates in two segments, Business and Consumer. The company offers virtual private network data network services; Ethernet services; Internet protocol services; CenturyLink Prism TV that allows customers to watch television or cable channels and record up to four shows on one home digital video recorder; and Vyvx, which provides audio and video feeds over fiber or satellite for broadcast and production customers, as well as satellite digital television services. It also provides broadband services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; private line solution for transmission of data between sites; colocation and data center services comprising cloud, hosting, and application management solutions; wavelength services that provide customers required bandwidth with an end-to-end transport solution of a bandwidth; and network security solutions, as well as sells telecommunications equipment and resells software, and provides network management, installation and maintenance of data equipment, and building of fiber-optic broadband networks. In addition, the company offers local calling services; long-distance and toll-free services; information technology (IT) services, such as transporting and delivering enterprise data and applications; and managed services consisting of network, hosting, cloud, and IT services. Further, it leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2017, the company operated approximately 10.3 million total access lines; and served approximately 5.7 million broadband subscribers. CenturyLink, Inc. was founded in 1968 and is based in Monroe, Louisiana.

#14 - Lending Club (NYSE:LC)

Dollar Amount of Shares Purchased: $128,604,359.62
Number of Insider Purchases in the Last 180 Days: 7
Volume of Shares Purchased: 33,733,191
Who Bought Shares: John J Mack (Director), Kenneth D Denman (Director), Thomas W Casey (CFO) and Tian Qiao Chen (Major Shareholder)

Insider Trades by Quarter for Lending Club (NYSE:LC)

Lending Club logoLendingClub Corporation operates an online marketplace platform that connects borrowers and investors in the United States. Its marketplace facilitates various types of loan products for consumers and small businesses, including unsecured personal loans, unsecured education and patient finance loans, auto refinance loans, and unsecured small business loans. The company also provides an opportunity to the investors to invest in a range of loans based on term and credit. LendingClub Corporation was founded in 2006 and is headquartered in San Francisco, California.

#15 - Valeant Pharmaceuticals International (NYSE:VRX)

Dollar Amount of Shares Purchased: $114,659,197.00
Number of Insider Purchases in the Last 180 Days: 5
Volume of Shares Purchased: 7,465,845
Who Bought Shares: John Paulson (Director), Joseph C Papa (CEO), Paul Herendeen (CFO) and Schutter Richard U De (Director)

Insider Trades by Quarter for Valeant Pharmaceuticals International (NYSE:VRX)

Valeant Pharmaceuticals International logoValeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

#16 - T-Mobile US (NASDAQ:TMUS)

Dollar Amount of Shares Purchased: $110,974,950.00
Number of Insider Purchases in the Last 180 Days: 8
Volume of Shares Purchased: 1,840,000
Who Bought Shares: Telekom Holding BV Deutsche (Major Shareholder)

Insider Trades by Quarter for T-Mobile US (NASDAQ:TMUS)

T-Mobile US logoT-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to 72.6 million customers in the postpaid, prepaid, and wholesale markets. It also provides wireless devices, including smartphones, tablets, and other mobile communication devices, as well as accessories that are manufactured by various suppliers. In addition, the company offers services, devices, and accessories under the T-Mobile and MetroPCS brands through its owned and operated retail stores, third party distributors, and its Websites. It also sells its devices to dealers and other third party distributors for resale through independent third-party retail outlets and various third-party Websites. As of December 31, 2017, T-Mobile US, Inc. operated approximately 2,200 T-Mobile and MetroPCS retail locations, including stores and kiosks. The company was founded in 1994 and is headquartered in Bellevue, Washington. T-Mobile US, Inc. is a subsidiary of Deutsche Telekom AG.







More on MarketBeat
15 REITS Analysts Can15 REITS Analysts Can't Stop Recommending
8 Companies Likely to Issue "Tax Cut" Dividend Increases8 Companies Likely to Issue "Tax Cut" Dividend Increases
13 Stocks Institutional Investors Won13 Stocks Institutional Investors Won't Stop Buying
7 Best Stocks to Own Right Now7 Best Stocks to Own Right Now
12 Cheap Dividend Stocks to Buy Today12 Cheap Dividend Stocks to Buy Today
5 Best Cryptocurrency Stocks to Buy Now5 Best Cryptocurrency Stocks to Buy Now
20 Stocks to Sell Now20 Stocks to Sell Now


Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.